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Synaptic Strength Regulated
by Palmitate Cycling on PSD-95
(NMDA) receptors are firmly tethered to the PSD (Moon
et al., 1994), whereas the -amino-3-hydroxy-5-methyli-
soxazole-4-propionic acid (AMPA) receptors are more
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loosely attached (Malenka and Nicoll, 1999; Malinow etAndrea Aguilera-Moreno,1 Roger A. Nicoll,1,2
al., 2000). Dynamic cycling of AMPA receptors on and offand David S. Bredt1,4
the synaptic membrane occurs in an activity-dependent1Department of Physiology
fashion and appears to underlie aspects of synaptic2 Department of Cellular
plasticity (Beattie et al., 2000; Ehlers, 2000; Lin et al.,and Molecular Pharmacology
2000; Lu¨scher et al., 1999; Man et al., 2000).University of California at San Francisco
Although mechanisms that control glutamate receptorSan Francisco, California 94143
numbers at the synapse are uncertain, proteins con-3 Kinsmen Laboratory
taining PDZ domains play a general role in recruitingDepartment of Psychiatry
receptors to synapses and other sites of cell-cell contactand the Brain Research Centre
(Craven and Bredt, 1998; Garner et al., 2000; KornauUniversity of British Columbia
et al., 1997; Lee and Sheng, 2000). PDZ domains areVancouver, British Columbia
modular protein motifs that bind to the extreme C terminiCanada
of interacting proteins (Kim et al., 1995; Kornau et al.,
1995) or with each other through PDZ-PDZ interactions
(Brenman et al., 1996a). The major PDZ protein at excit-Summary
atory synapses is PSD-95/SAP-90 (Cho et al., 1992; Kist-
ner et al., 1993), a membrane-associated guanylateDynamic regulation of AMPA-type glutamate recep-
kinase (MAGUK), which functions as a multivalent syn-tors represents a primary mechanism for controlling
aptic scaffolding protein. The PDZ domains from thesynaptic strength, though mechanisms for this pro-
postsynaptic density protein (PSD-95) were first showncess are poorly understood. The palmitoylated post-
to bind the C-terminal tails of NMDA receptor type-2synaptic density protein, PSD-95, regulates synaptic
subunits (Kornau et al., 1995) and Shaker-type K chan-plasticity and associates with the AMPA receptor traf-
nels (Kim et al., 1995). However, the PSD-95 family officking protein, stargazin. Here, we identify palmitate
MAGUKs can also interact with AMPA receptors. Thecycling on PSD-95 at the synapse and find that palmi-
C terminus of glutamate receptor subunit-1 (GluR1)tate turnover on PSD-95 is regulated by glutamate
binds directly to MAGUK protein SAP-97 (Leonard etreceptor activity. Acutely blocking palmitoylation dis-
al., 1998); furthermore, the AMPA receptor traffickingperses synaptic clusters of PSD-95 and causes a se-
protein, stargazin, associates with PDZ domains fromlective loss of synaptic AMPA receptors. We also find
several neuronal MAGUKs (Chen et al., 2000).that rapid glutamate-mediated AMPA receptor inter-
By interacting with glutamate receptors, cell adhesionnalization requires depalmitoylation of PSD-95. In a
molecules, and cytoskeletal elements (Irie et al., 1997;nonneuronal model system, clustering of PSD-95,
Kim et al., 1997; Kornau et al., 1997), MAGUK proteinsstargazin, and AMPA receptors is also regulated by
regulate synapse development and plasticity. Disruptionongoing palmitoylation of PSD-95 at the plasma mem-
of discs large (DLG), a Drosophila MAGUK, perturbsbrane. These studies suggest that palmitate cycling on
postsynaptic structure and blocks clustering of Shaker-PSD-95 can regulate synaptic strength and regulates
type K channels that normally associate with DLG (Te-aspects of activity-dependent plasticity.
jedor et al., 1997). In cultured hippocampal neurons,
overexpression of PSD-95 accelerates development of
Introduction excitatory synapses and selectively enhances clustering
of AMPA receptors (El-Husseini et al., 2000b). On the
Excitatory signaling in the brain occurs primarily at syn- other hand, targeted disruption of PSD-95 causes se-
apses that employ glutamate as a neurotransmitter. The vere abnormalities of synaptic plasticity, such that long-
ionotropic glutamate receptors are clustered with asso- term potentiation (LTP) is enhanced and long-term de-
ciated downstream signaling enzymes in the postsynap- pression (LTD) is eliminated (Migaud et al., 1998). These
tic density (PSD), a thickening of the cytoskeleton be- abnormalities in synaptic plasticity presumably explain
neath the plasma membrane (Kennedy, 1997; Walters why PSD-95 mutant mice are impaired in spatial learning
and Matus, 1975). This clustered arrangement facilitates (Migaud et al., 1998).
rapid and efficient transmission; however, the PSD is How might PSD-95 dynamically regulate synaptic gluta-
also a dynamic structure. Changes in glutamate receptor mate receptors and synaptic plasticity? Phosphorylation
number at the PSD provide a critical mechanism for of DLG within PDZ1 by calcium/calmodulin-dependent
rapidly altering synaptic strength (Malenka and Nicoll, protein kinase regulates clustering at the Drosophila
1999; Malinow et al., 2000). Interestingly, the two princi- neuromuscular junction (Koh et al., 1999), but it is uncer-
ple classes of ionotropic glutamate receptors are differ- tain whether this mechanism applies for PSD-95 in the
entially anchored at the PSD. The N-methyl-D-aspartate brain. In addition to its PDZ motifs, PSD-95 contains
several other domains that could help explain its role.
The C-terminal half of PSD-95 comprises an SH3 and a4 Correspondence: bredt@phy.ucsf.edu
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guanylate kinase domain, which both function as pro- times higher dose significantly enhanced clustering of
PSD-95 (Figures 1A and 1B). The effects of 2-Br palmi-tein-protein interaction motifs (Craven and Bredt, 1998;
Garner et al., 2000; Lee and Sheng, 2000). Interestingly, tate on clustering are not simply due to disrupting palmi-
toylation of newly synthesized PSD-95, as cycloheximidethese domains also can bind each other in both intra-
and intermolecular orientations (McGee and Bredt, (CHX), which effectively blocks synthesis of PSD-95 (Sup-
plemental Figure S2, http://www.cell.com/cgi/content/1999; Shin et al., 2000). However, it is not yet clear how
the SH3 or GK domains might be regulated in an activity- full/108/6/849/DC1), does not disperse PSD-95 synaptic
clusters (Figures 1A and 1B).dependent fashion.
PSD-95 also contains two critical cysteine residues Many palmitoylated proteins, including PSD-95, are
insoluble in nonionic detergents (Cho et al., 1992, Kistnerat positions 3 and 5, which are sites of protein palmitoy-
lation (Topinka and Bredt, 1998). This posttranslational et al., 1993). As a surrogate assay for palmitoylation, we
monitored the solubility of PSD-95 in neurons treatedmodification involves addition of palmitate, a 16-carbon
fatty acid, via a labile thioester linkage (Dunphy and with 2-bromopalmitate. Neurons were homogenized,
lysed in hypotonic buffer, and lysates were centrifugedLinder, 1998; Resh, 1999). Palmitoylation of PSD-95 is
essential for clustering at the PSD (Craven et al., 1999). to separate cytosolic (soluble) and membrane (particu-
late) fractions. The ratio of PSD-95 in the soluble/particu-Akin to protein phosphorylation, palmitoylation is a re-
versible process that is dynamically regulated by spe- late fractions (S/P ratio) was quantified by gel densitom-
etry. As previously described, the majority of PSD-95 incific cellular stimuli (Milligan et al., 1995; Mumby, 1997).
We therefore asked whether this lipidation of PSD-95 is cultured hippocampal neurons is insoluble (S/P  34 
12, n  6); however, treatment with 2-bromopalmitateactivity dependent at the synapse and whether this
might regulate glutamate receptor function. dramatically increased the soluble fraction of PSD-95
(S/P 79 8, n 6; Figure 1D). Interestingly, treatmentHere, we identify palmitate turnover on PSD-95 at the
synapse. This palmitate cycling occurs in an activity- with palmitate itself reduced the soluble fraction of PSD-
95 (S/P  19  9, n  5), suggesting it may not be fullydependent fashion, and acutely disrupting palmitoyla-
tion with 2-bromopalmitate disperses synaptic clusters palmitoylated in normal culture conditions.
of PSD-95. This activity-dependent dispersion of PSD-
95 results in a selective loss of AMPA receptor subunits
and AMPA receptor activity at synapses. Preventing de- Palmitate Cycling on PSD-95 Is Regulated
by Synaptic Activitypalmitoylation of PSD-95 blocks glutamate-mediated in-
ternalization of AMPA receptors. Surface clusters of As palmitate turnover on the  subunit of certain G pro-
teins is regulated by activation of their upstream recep-PSD-95, stargazin, and AMPA receptor subunits that
form in transfected heterologous cells also require on- tors (Wedegaertner and Bourne, 1994), we asked
whether palmitate turnover on PSD-95 might be regu-going palmitoylation of PSD-95 at the plasma mem-
brane. These studies suggest that protein palmitoylation lated by glutamate receptor activity. Indeed, we found
that blocking glutamate receptors with kynurenic acid,is regulated in an activity-dependent fashion at the syn-
apse and suggest mechanisms for plasticity regulated an ionotropic glutamate receptor antagonist, blocked
the declustering of PSD-95 by 2-bromopalmitate (Fig-by palmitate cycling on PSD-95.
ures 2A and 2B). Similarly, we found that blocking gluta-
mate receptors with a combination of CNQX, which
blocks AMPA receptors and APV, which blocks NMDAResults
receptors, also inhibited declustering of PSD-95 by
2-bromopalmitate (Figure 2B). To determine if calciumDynamic Turnover of Palmitate on PSD-95
at the Synapse is required for this process, we treated neurons with
2-Br palmitate in the absence of extracellular calciumPrevious studies have shown that palmitoylation of PSD-
95 is essential for its clustering at synapses (Craven et and found that removing calcium protected clustering
and palmitoylation of PSD-95 (Figures 2A and 2B). Theseal., 1999). To determine whether palmitoylation of PSD-
95 is a dynamic process at the synapse, we treated results indicate that calcium entry associated with gluta-
mate receptor activity is critical for depalmitoylation. Incultured hippocampal neurons (DIV 14) with 2-bromo-
palmitate, a drug that potently blocks palmitoylation by contrast, treatment with glutamate receptor antagonists
or removing extracellular calcium alone did not de-blocking protein acyl-transfer (Webb et al., 2000). We
found that incubation of neurons with 10 M 2-bromo- tectably change PSD-95 clustering (Figure 2B).
The activity-dependent loss of synaptic PSD-95 thatpalmitate dispersed synaptic clusters of PSD-95 (Fig-
ures 1A and 1B) and blocked palmitoylation of PSD-95 occurs in the presence of 2-bromopalmitate has two
possible explanations: (1) depalmitoylation of PSD-95(Figure 1C). This treatment did not affect clustering of
synaptophysin, a presynaptic marker used as a control is accelerated by glutamate receptor activity, or (2) diffu-
sion of palmitate-free PSD-95 from the synapse requires(Figure 1A). This effect was also seen with 2-bromopalmi-
toyl-CoA (Figure 1B), which also inhibits protein palmitoy- glutamate receptor activity. To help to distinguish be-
tween these two possibilities, we quantitated the cyclinglation (data not shown). Synaptic clusters of PSD-93
(Brenman et al., 1996b; Kim et al., 1996), a palmitoylated of palmitate on PSD-95. Palmitate turnover on PSD-
95 in neurons was monitored by metabolically labelingMAGUK (El-Husseini et al., 2000c) related to PSD-95,
are also dispersed by 2-Br palmitate (Supplemental Fig- hippocampal cultures with [125I]palmitate, which is a sen-
sitive radioactive precursor that is incorporated faithfullyure S1, http://www.cell.com/cgi/content/full/108/6/
849/DC1). As a control, we found that palmitate at a 10 into palmitoylated proteins (Berthiaume et al., 1995).
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Figure 1. Blocking Palmitoylation Disperses Synaptic Clusters of PSD-95
(A) Cultured hippocampal neurons (DIV 14) were treated for 8 hr with 10 M 2-bromopalmitate (2-Br Palm), 2-bromo palmitoyl-CoA (2-Br Palm
CoA), 10 g/ml cycloheximide (CHX), 16-hydroxypalmitate (16-OH Palm), or 10 m palmitate (Palm), or palmitate. Neurons were then fixed
and stained for PSD-95 and synaptophysin. Treatment with agents that block protein palmitoylation results in declustering of PSD-95. In
contrast, treatment with palmitate slightly enhanced clustering of PSD-95. Cycloheximide did not alter PSD-95 clustering, and none of the
treatments changed synaptophysin staining.
(B) Quantitative analysis of the intensity of PSD-95 clusters after these treatments. Treatment with 2-Br Palm or 2-Br Palm-CoA significantly
reduced PSD-95 clustering (p  0.001), whereas treatment with palmitate significantly enhanced (p  0.01) PSD-95 clustering when compared
to cells treated with vehicle.
(C) 2-Bromopalmitate blocks palmitoylation of PSD-95. Neurons were treated with [125I]palmitate and either vehicle or 10 M 2-bromopalmitate
for three hours. PSD-95 was purified by immunoprecipitation; [125I] incorporation was visualized by autoradiography; and PSD-95 protein was
visualized by Western blotting (W.B.).
(D) Blocking palmitoylation increases the solubility of PSD-95. After treatment with 2-bromopalmitate or palmitate, neurons were harvested
and the lysate (L) was subjected to protein fractionation (see Experimental Procedures). Treatment with 2-bromopalmitate increased the
amount of PSD-95 in the soluble fraction (S). In contrast, PSD-95 in untreated or palmitate-treated cultures was primarily in the pellet (P).
Scale bar, 10 m.
Cell
852
Figure 2. Synaptic Clustering of PSD-95 Is
Regulated by Glutamate Receptor Activity
(A) Declustering of PSD-95 by 2-bromopalmi-
tate (2-Br Palm) requires glutamate receptor
activity. Cultures were treated with vehicle
or with 2-bromopalmitate in the absence or
presence of 10 mM kynurenate (Kyn) or low-
extracellular calcium (Ca2). Blocking gluta-
mate receptors or eliminating extracellular
calcium blocks the effect of 2-bromopalmi-
tate on declustering of synaptic PSD-95 (red),
but had no effect on the presynaptic marker,
synaptophysin (green).
(B) A graph summarizes the quantitative
changes in the intensity of PSD-95 clusters
after these treatments, or 100 M CNQX and/
or 100 M APV. In all treatments with gluta-
mate receptor antagonists, PSD-95 cluster-
ing was significantly higher than in cells
treated with 2-Br-palmitate alone (p 0.001).
Scale bar, 10 m.
We found that the half-life of palmitate on PSD-95 is com/cgi/content/full/108/6/849/DC1). Importantly, the
half-life of palmitate on PSD-95 was substantially in-approximately 2 hr, whereas the half-life of PSD-95 pro-
tein itself is much longer, approximately 36 hr (Figures creased in the presence of kynurenic acid (Figures 3A
and 3B). Conversely, glutamate treatment (10 M) re-3A and 3B, and Supplemental Figure S2, http://www.cell.
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Figure 3. Regulation of Palmitate Turnover on PSD-95 by Glutamate Receptor Activity
(A) Turnover of palmitate on PSD-95 is regulated by glutamate receptor activity. Hippocampal neurons were labeled with [125I]palmitate for 3
hr or with [35S]methionine for 1 hr. Cultures were treated with vehicle (Veh) or with 10 mM kynurenate for 0, 1, 3, and 6 hr; cells were
lysed; and PSD-95 was immunoprecipitated from the solubilized material. Immunoprecipitates were loaded onto gels that were analyzed by
fluorography for [125I]palmitate (upper gel), [35S]methionine (middle gel), or were immunoblotted for PSD-95 (lower gel).
(B) A graph showing that the half-life (t1/2) of palmitoylated PSD-95 is prolonged by blocking glutamate receptors with kynurenate.
(C) Treating neurons with glutamate (10 M) significantly accelerates (p  0.001) the turnover of [125I]palmitate on PSD-95. Metabolic pulse-
chase labeling of cultures and analysis of PSD-95 was done as described in (A).
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duced the half-life of palmitate on PSD-95 (Figure 3C). were resistant to treatment with 2-bromopalmitate (Fig-
ures 6C–6E).These data indicate that glutamate receptor activity
stimulates palmitate turnover on PSD-95. We used the PSD-95-prenyl mutant to assess a possi-
ble role for palmitate cycling on PSD-95 in activity-
dependent turnover of AMPA receptors. These experi-Palmitate Cycling on PSD-95 Regulates Synaptic
ments employed an “antibody feeding” immunofluores-AMPA Receptors
cence internalization assay to quantify AMPA receptorNMDA receptors directly bind PSD-95 (Kornau et al.,
endocytosis. As previously reported (Beattie et al., 2000;1995) whereas AMPA receptors, which are indirectly
Ehlers, 2000; Lin et al., 2000; Zhou et al., 2001), 15 minassociated (Chen et al., 2000), are recruited to synapses
exposure to glutamate (100 M) enhances internaliza-by PSD-95 overexpression (El-Husseini et al., 2000b).
tion of AMPA receptor subunit GluR1 (Figure 7). TheWe therefore asked whether the 2-bromopalmitate-
internalized AMPA receptor vesicles accumulate in bothinduced loss of synaptic PSD-95 affects associated
the cell body and dendritic processes. This glutamate-glutamate receptors. Immunohistochemical staining of
mediated AMPA receptor internalization was enhancedhippocampal cultures treated with 2-bromopalmitate
in cells transfected with wild-type PSD-95 (Figure 7); thisshowed synaptic clustering of the AMPA receptor sub-
enhancement likely results from the increased synapticunit GluR1 is diminished (Figures 4A–4C). The loss of
expression of AMPA receptors in PSD-95-transfectedGluR1 at synapses was quantitatively similar to that of
neurons (El-Husseini et al., 2000b). Importantly, gluta-PSD-95. On the other hand, synaptic clustering of NMDA
mate-mediated AMPA receptor internalization was abol-receptors as measured by NMDA receptor subunits 1 or
ished in cells transfected with PSD-95-prenyl (Figure 7),2B (NR1 or NR2B) was unaffected by 2-bromopalmitate
indicating that palmitoylation is critical for this regulated(Figures 4B and 4C)
AMPA receptor turnover. Neither wild-type PSD-95 norWe next asked whether disrupting PSD-95 clustering
PSD-95-prenyl affected basal AMPA receptor internal-with 2-bromopalmitate causes specific changes in gluta-
ization (Figure 7).matergic function. AMPA-mediated miniature excitatory
postsynaptic currents (mEPSCs) were monitored with
Regulation of AMPA Receptor Clusteringwhole-cell recordings from cultured hippocampal neurons
by Palmitate Turnover on PSD-95by an investigator blinded with regard to 2-bromopal-
To determine whether the role of palmitate cycling inmitate treatment. These experiments revealed a signifi-
clustering of PSD-95 and AMPA receptors can be repro-cant reduction in the amplitude and frequency of synap-
duced in a model system that lacks the molecular com-tic events in 2-bromopalmitate-treated neurons (Figures
plexity of neuronal synapses, we evaluated clustering5A–5C). These data suggest a decrease in the number
in heterologous cells. In this model, cotransfection ofof functional AMPA receptors at synaptic sites and are
COS cells with PSD-95, the glutamate receptor targetingconsistent with the reduction in punctate GluR1 immu-
protein stargazin, and the AMPA receptor subunitnostaining. The selective reduction in AMPA receptor
GluR4, yields clusters of the three proteins that appearimmunostaining relative to NMDA receptor staining in
as patches along the plasma membrane (Chen et al.,2-bromopalmitate-treated cells predicts a reduction in
2000). Treating cultures with 2-bromopalmitate dis-the ratio of synaptic AMPA receptors to NMDA receptors
persed these preformed clusters and caused all threeat individual synapses. We therefore recorded dual com-
proteins to redistribute to perinuclear vesicles that sug-ponent mEPSCs using conditions that allowed us to
gest an intracellular accumulation (Figure 8A). This ve-assay AMPA and NMDA currents simultaneously. We
sicular distribution of PSD-95 and stargazin/GluR4 isfound that the ratio of AMPA-mediated currents to
also observed in transfections with a palmitoylation-NMDA-mediated currents was significantly reduced in
deficient mutant of PSD-95 (Figure 8A). This localizationthe 2-bromopalmitate-treated cells (Figures 5D and 5E),
resembles the ER/golgi accumulations of palmitoyla-demonstrating a selective effect of 2-bromopalmitate
tion-deficient PSD-95 cotransfected with Kv1.4 (Tiffanyon synaptic AMPA receptor function.
et al., 2000). To verify that the effects of 2-bromopalmi-This loss of synaptic GluR1 in 2-bromopalmitate-treated
tate on PSD-95/stargazin/GluR4 in heterologous cells arecultures may result from changes in palmitoylation of PSD-
specific for palmitoylation of PSD-95, we used the preny-95 or from loss of palmitate on other proteins. To help
lated mutant of PSD-95. When this construct was cotrans-to assess this, we employed a palmitoylation-deficient
fected with stargazin and GluR4, receptor clustering isPSD-95 mutant (PSD-95-prenyl) that is isoprenylated at
also observed (Figure 8B). Although these clusters areits C terminus (Figure 6A) and recruited to synapses
smaller than those observed with the palmitoylated ver-independent of palmitoylation (El-Husseini et al., 2000a).
sion, they appear to be on the plasma membrane andWe transfected neurons with constructs encoding GFP
otherwise resemble those found with palmitoylatedfused either to wild-type PSD-95 or to PSD-95-prenyl
PSD-95. Importantly, these clusters formed with PSD-and assessed the effects of 2-bromopalmitate on synap-
95-prenyl are resistant to treatment with 2-bromopalmi-tic clustering. As previously published (El-Husseini et al.,
tate, confirming the specificity of this drug for palmitoy-2000b), AMPA receptor clusters are enhanced in neurons
lated PSD-95 (Figure 8B).transfected with PSD-95 (Figures 6B and 6E), and these
clusters are diminished following treatment with 2-bro-
mopalmitate (Figures 6C–6E). PSD-95-prenyl also en- Discussion
hanced synaptic clustering of GluR1 in transfected cells
(Figures 6C and 6E). However, these synaptic AMPA This study identifies palmitate turnover on PSD-95 as a
critical regulatory mechanism at the synapse. This cy-receptor clusters, as well as those of prenyl-PSD-95,
Palmitate Cycling on PSD-95
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Figure 4. Blocking Protein Palmitoylation
Declusters Synaptic AMPA but Not NMDA
Receptors
(A) Treatment of neurons with 2-bromopalmi-
tate (2-Br Palm) yields a reduction of synaptic
GluR1 clustering that correlates with the de-
palmitoylation-induced loss of synaptic PSD-
95. Hippocampal neurons were treated with
10 M 2-bromopalmitate for 8 hr, then fixed
and stained for PSD-95 (green) and GluR1
(red).
(B) 2-Bromopalmitate disperses synaptic
clusters of GluR1 but not NR1. Hippocampal
neurons treated with 2-bromopalmitate were
fixed and stained for NR1 (green) and GluR1
(red).
(C) A graph summarizes the quantitative
changes in the intensity of GluR1, NR1, and
NR2B after treatment with 2-bromopalmitate.
Treatment with 2-bromopalmitate signifi-
cantly reduced GluR1 clustering (p  0.001),
but not NR1 (p 0.1) or NR2B (p 0.2). Scale
bar, 10 m.
cling of palmitate is regulated by glutamate receptor mediated AMPA receptor internalization. Regulated pal-
mitoylation of PSD-95 therefore represents a novel phys-activity, and interrupting this cycle with 2-bromopalmi-
tate disperses PSD-95 and AMPA receptor clusters. Dis- iological mechanism for activity-dependent changes in
synaptic strength.rupting palmitate cycling on PSD-95 blocks glutamate-
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Figure 5. Alteration of AMPA-Receptor Mediated Synaptic Activity by Inhibition of Palmitoylation
(A) 2-Bromopalmitate treatment reduces the amplitude and frequency of AMPA-receptor mediated miniature postsynaptic currents (mEPSCs).
Hippocampal neurons were treated with vehicle (control) or with 20 M 2-Br Palm for 8 hr and whole-cell voltage clamp recordings were
made in the presence of picrotoxin and TTX to isolate AMPA-mediated spontaneous synaptic responses. Sample traces from representative
neurons are shown. Scale bars 10 pA, 20 msec.
(B) Mean mEPSC amplitude is reduced in 2-Br Palm treated cells (vehicle, n  14; 2 Br Palmitate, n  15; p  0.005).
(C) Mean mEPSC frequency is also reduced by 2-Br Palm treatment (p  0.05).
(D) Cultured hippocampal neurons were recorded in the presence of 20 M glycine and 0 mM magnesium to evoke dual component (AMPA 
NMDA) responses at –70 mV. Representative averaged mEPSCs from control and 2-Br Palm treated neurons are shown, demonstrating a
reduction in the AMPA-mediated (fast) component of the response and preservation of the NMDA-mediated (slow) component. Scale bars
10 pA, 10 msec.
(E) The ratio of the AMPA-receptor-mediated component to that of the NMDA-receptor mediated component is significantly reduced in 2-Br
palmitate treated cells (vehicle, n  12; 2 Br Palmitate; n  11; p  0.05).
Regulation of the Dynamic Pool of AMPA ion channels at the synapse (Craven and Bredt, 1998;
Garner et al., 2000; Hayashi et al., 2000; Lee and Sheng,Receptors by PSD-95
Previous studies have shown that PSD-95 and related 2000; Tejedor et al., 1997). PDZ domains from PSD-95
directly bind the C termini of NMDA receptor subunitsMAGUKs interact with glutamate receptors and other
Palmitate Cycling on PSD-95
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and other proteins terminating with a tSXV motif (Kim are consistent with previous studies showing that the
palmitoylation-deficient mutant PSD-95 (C3, 5S) en-et al., 1995; Kornau et al., 1997). This PDZ binding se-
quence is also present on the AMPA receptor trafficking hances internalization of the associated ion channel Kv
1.4 (Jugloff et al., 2000).protein, stargazin (Chen et al., 2000). Stargazin is a tet-
raspanin transmembrane protein that interacts with In neurons, blocking palmitoylation also disperses
preformed synaptic clusters of PSD-95. This suggestsAMPA receptors and is essential for their targeting to
the plasma membrane (Chen et al., 2000; Tomita et al., that maintenance of PSD-95 synaptic clusters requires
ongoing palmitoylation. Importantly, palmitate turnover2001). By binding to the PDZ domain of PSD-95, star-
gazin indirectly links AMPA receptors to PSD-95. on PSD-95 is regulated by glutamate receptor activity,
as glutamate receptor antagonists prolong the half-lifeThrough these PDZ interactions, PSD-95 can mediate
clustering of either NMDA receptors (Lee and Sheng, of palmitate on PSD-95 and prevent declustering of
PSD-95 by 2-bromopalmitate. This stimulation of palmi-2000) or stargazin/AMPA receptors (Chen et al., 2000)
in heterologous cells. tate turnover by activation of an upstream glutamate
receptor is reminiscent of receptor-activated palmitateAn essential role for PSD-95 in glutamate receptor
clustering at the synapse is less certain. Dislodging cycling on signaling proteins in nonneuronal cells. An
elegant series of studies has shown that activation of 	PSD-95 from synapses with peptides that block its bind-
ing to the cytoskeletal protein CRIPT does not disrupt adrenergic receptors stimulates palmitate turnover on
Gs (Wedegaertner and Bourne, 1994). This depalmitoy-synaptic NMDA receptor clusters (Passafaro et al.,
1999). The converse strategy—overexpressing PSD-95 lation downregulates G protein signaling by both (A)
removing G from the plasma membrane and (B) en-in neurons—causes a selective enhancement in synap-
tic AMPA receptors whereas NMDA receptors are unal- hancing deactivation of Gby RGS proteins (Resh, 1996;
Tu et al., 1997). Agonist-stimulated depalmitoylation oftered (El-Husseini et al., 2000b). Furthermore, in mutant
mice lacking PSD-95, there is no change in the distribu- endothelial nitric oxide synthase also disrupts its mem-
brane localization and activity (Robinson et al., 1995).tion or activity of NMDA receptors though there are clear
changes in synaptic plasticity (Migaud et al., 1998). Our The cytosolic tails of some receptors are also palmitoy-
lated, and this can regulate receptor-mediated endocy-studies show that disrupting palmitoylation of PSD-95
with 2-bromopalmitate decreases the number and fre- tosis (Alvarez et al., 1990). By analogy, our studies show
that activity-dependent depalmitoylation causes PSD-quency of miniature EPSCs consistent with the decreased
immunohistochemical staining for AMPA receptor sub- 95 to diffuse from the PSD and downregulates synaptic
AMPA receptors (Figure 8C). Taken together, these dataunits. Additionally, 2-bromopalmitate selectively affects
AMPA receptors, but not NMDA receptors. Taken to- suggest that agonist-stimulated palmitate turnover may
represent a common mechanism for dampening recep-gether, these studies suggest that PSD-95 is not essen-
tial for recruiting the constitutive pool of synaptic NMDA tor activated signaling.
receptors, but that PSD-95 regulates a dynamic pool of
AMPA receptors.
Palmitate Turnover Regulating Synaptic Function
The enzymes that regulate palmitoylation of PSD-95 at
the synapse remain unidentified. Our previous studiesPalmitate Turnover Regulated by Synaptic Activity
Palmitoylation of residues of 3 and 5 plays an essential showed that the N terminus of PSD-95 contains a five
amino acid consensus sequence that determines palmi-role in synaptic targeting of PSD-95 and in clustering of
associated receptors (Craven et al., 1999; Topinka and toylation (El-Husseini et al., 2000a). However, the protein
acyl-transferase that recognizes this sequence and me-Bredt, 1998). Palmitoylation of PSD-95 occurs first in the
neuronal cell body and targets PSD-95 to a perinuclear diates palmitoylation and the protein thioesterase that
removes the palmitate remain uncertain. For this reason,endomembrane system (El-Husseini et al., 2000a). The
pathway for trafficking PSD-95 from perinuclear endo- it is unclear how glutamate receptor activity stimulates
palmitate turnover. One possibility is that the proteinsomes to synaptic clusters is uncertain, but some in-
sights have been gained from studies of receptor clus- thioesterase is a second messenger-regulated enzyme
whose activity is stimulated by calcium influx or proteintering with PSD-95 in heterologous cells. In COS cells
cotransfected with PSD-95 and an interacting ion chan- phosphorylation at the postsynaptic density. Alterna-
tively, synaptic activity may make the N terminus ofnel, clusters of both proteins form on the plasma mem-
brane. Live cell-imaging shows that these surface PSD-95 more accessible to the thioesterase in a mecha-
nism akin to that proposed for receptor-stimulated pal-patches are derived from dynamic vesiculotubular trans-
port intermediates for PSD-95-GFP that fuse with the mitate turnover on G protein subunits. Isolation of the
proteins that mediate addition and removal of palmitateplasma membrane (El-Husseini et al., 2000a), sug-
gesting that PSD-95 regulates vesicular trafficking of will help address these issues.
PSD-93, a close homolog of PSD-95 is palmitoylated,receptors. On the plasma membrane, these PSD-95/
ion channel clusters are immobile (Burke et al., 1999); expressed in hippocampal neurons, and can interact
with stargazin. Furthermore, synaptic clusters of PSD-however, studies here indicate that these are not static
structures. Acutely blocking palmitoylation disperses 93 are dispersed by 2-Br palmitate. This isoform redun-
dancy may explain why basal synaptic transmission re-these clusters and causes both PSD-95 and the inter-
acting stargazin/AMPA receptors to redistribute to peri- mains intact in PSD-95 mutant mice (Migaud et al., 1998).
In addition to PSD-95 and PSD-93 (El-Husseini et al.,nuclear endosomal structures, suggesting that depalmi-
toylation enhances receptor endocytosis. These data 2000c), a variety of proteins associated with gluta-
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Figure 6. Palmitoylation-Dependent Cluster-
ing of AMPA Receptors Specifically Involves
PSD-95
(A) Schematic diagrams of palmitoylated PSD-
95 GFP and palmitoylation-deficient PSD-95
GFP containing a C-terminal prenylation motif
(PSD-95-Prenyl). (B and C) Hippocampal neu-
rons were transfected with either PSD-95
GFP (PSD-95) or with PSD-95-GFP-Prenyl
(PSD-95 Prenyl) and were treated with vehicle
or with 10 M 2-bromopalmitate (2-Br Palm)
for 8 hr. Neurons were then fixed and stained
for GluR1 (red) and the PSD-95 was visualized
on the green channel.
(B) GluR1 clusters in neurons transfected with
PSD-95 GFP (arrowheads) were enhanced
relative to untransfected neurons (arrows).
(C) Treatment with 2-bromopalmitate dimin-
ished clustering of PSD-95 GFP and GluR1.
However, the prenylated PSD-95 GFP and as-
sociated GluR1 clusters were resistant to
2-bromopalmitate treatment. Note in (C) that
the neuron transfected with PSD-95-GFP-
prenyl shows strong GluR1 clusters (arrow-
heads) that are resistant to 2-bromopalmitate,
whereas the untransfected neighbors show
minimal GluR1 clusters (arrows). Scale bar,
10 m.
(D) Quantitative analysis shows that 2-bro-
mopalmitate significantly reduces synaptic
clusters of transfected PSD-95-GFP (p 
0.001), but has no significant effect on synap-
tic clustering of PSD-95-GFP-prenyl.
(E) Quantitative analysis shows that synaptic
clusters of GluR1 in cells transfected with
PSD-95-GFP are reduced by 2-bromopalmi-
tate (p  0.001). By contrast, GluR1 clusters
in cells transfected with PSD-95-GFP-prenyl
are resistant to 2-bromopalmitate.
matergic transmission are regulated by palmitoylation, the PSD suggests that this protein modification may play
and inhibiting their palmitoylation could influence syn- multiple important roles at the synapse. Our studies of
aptic function. These include the metabotropic gluta- activity-regulated cycling of palmitate on PSD-95 should
mate receptor mGluR4 (Alaluf et al., 1995), the kainate serve as a prototype for understanding how this mecha-
receptor subunit GluR6 (Pickering et al., 1995), and the nism can regulate synaptic structure and function.
glutamate receptor interacting protein GRIP (Yamazaki
et al., 2001). Changes in palmitoylation of these proteins
Experimental Proceduresare unlikely to explain the effects observed here, as we
found that expression of a palmitate-resistant mutant
cDNA Cloning and Mutagenesis
of PSD-95 (PSD-95-prenyl) blocked the effects of 2-bro- Constructs encoding PSD-95 and PSD-95 (C3, 5S) fused to GFP in
mopalmitate on AMPA receptor clustering and prevented GW1 vectors were described previously (Craven et al., 1999). The
glutamate-mediated AMPA receptor internalization. PSD-95-GFP-prenyl chimera was generated by appending oligos
encoding the prenylation motif of paralemmin (amino acids:Nevertheless, palmitoylation of numerous proteins at
Palmitate Cycling on PSD-95
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Figure 7. Palmitoylation-Regulated Internalization of AMPA Receptors Mediated by PSD-95
Endocytosis of AMPA receptors (GluR1) was analyzed by an immunofluorescence internalization assay. Hippocampal neurons were transfected
with either PSD-95 GFP (PSD-95) or with PSD-95-GFP-prenyl (PSD-95 Prenyl), and following glutamate treatment (15 min, 100 M), neurons
were fixed and stained for internalized AMPA receptors (GluR1; red). Glutamate enhances internalization of GluR1 in untransfected cells (top
panels). PSD-95-GFP overexpression (arrows) enhances the effect of glutamate on internalization of GluR1 as compared to untransfected
cells (arrowheads; middle panels). In contrast, the prenylated PSD-95-GFP (arrows) prevents glutamate-induced GluR1 internalization as
compared to neighboring untransfected cells (arrowheads; lower panels). Quantitative analysis shows that glutamate increases GluR1 internal-
ization relative to untreated cells (p  0.01), that overexpression of PSD-95-GFP significantly enhances this internalization (p  0.01), and
that PSD-95GFP-prenyl abolishes the glutamate-stimulated internalization (p  0.01). Scale bar, 10 m.
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Figure 8. Assembly of the Stargazin-Glutamate Receptor Complex by PSD-95 Is Modulated by Palmitoylation
(A) Depalmitoylation of PSD-95 inhibits clustering of stargazin and GluR4. COS cells were cotransfected with GluR4, stargazin-GFP (Stg GFP),
and wild-type PSD-95. Twelve hours posttransfection, cells were treated with vehicle or 10 M 2-bromopalmitate (2-Br Palm) for 8 hr then
were stained with antibodies to PSD-95 (blue) and GluR4 (red); stargazin was visualized on the green channel. Treatment with 2-bromopalmitate
blocks clustering of PSD-95, stargazin, and GluR4, and causes all three proteins to accumulate in a perinuclear pattern that resembles the
distribution of the proteins in cells cotransfected with the palmitoylation-deficient mutant of PSD-95 (PSD-95:C3,5S).
(B) Stargazin and GluR4 are also clustered by a prenylated PSD-95 mutant (GFP-PSD-95-prenyl), though the clusters are somewhat smaller
and more punctate than with wild-type PSD-95. Importantly, the stargazin/AMPA receptor clusters with GFP-PSD-95-prenyl are resistant to
2-bromopalmitate.
(C) Schematic diagram of activity-dependent palmitate cycling on PSD-95 at the synapse. 2-bromopalmitate causes accumulation of depalmi-
toylated PSD-95 and decreases synaptic AMPA receptors and synaptic activity enhances depalmitoylation of PSD-95.
Palmitate Cycling on PSD-95
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DMKKHRSKSCSIM) to the C terminus of the PSD-95 (C3, 5S) GFP 106 cells/well) were labeled for 3 hr in neurobasal media containing
25 Ci/ml [125I]palmitic acid. For metabolic labeling with [35S]methio-construct.
nine, cells were incubated for 15 min with methionine-free neuroba-
sal media and then for 1 hr in this media containing 300 Ci/mlPrimary Neuronal Culture, Transfection,
and Immunofluorescence EXPRE35S35S methionine (1175 Ci/mmol; NEN Life Science Products,
Inc.). For cycloheximide treatment, 10g/ml was added to neuroba-Neuronal cultures were prepared from hippocampi of E18/E19 rats.
Hippocampi were dissociated by enzyme digestion with papain fol- sal media. For pulse-chase experiments using [125I]palmitate and
[35S]methionine, cells were washed once with neurobasal media andlowed by brief mechanical trituration. Cells were plated on poly-D-
lysine (Sigma) treated glass coverslips (12 mm in diameter), and then were incubated for variable times in conditioned neurobasal
media containing 100 M palmitate or 2 mM methionine, respec-maintained in neurobasal media (Gibco) supplemented with B27,
penicillin, streptomycin, and L-glutamine as described in Brewer tively. Labeled cells were washed with ice-cold PBS and resus-
pended in 0.1 ml lysis buffer containing TEE (50 mM Tris-HCl [pHet al. (1993). For transfection of PSD-95 GFP and mutant forms,
hippocampal cultures were transfected by lipid-mediated gene 7.4], 1 mM EDTA, 1 mM EGTA), 150 mM NaCl, and 1% SDS. After
extracting for 5 min at 4
C, Triton X-100 was added to 1% to neutral-transfer kit (DOTAP) as described (Craven et al., 1999).
Coverslips were removed from culture wells and fixed in methanol ize the SDS in a final volume of 0.5 ml. Insoluble material was
removed by centrifugation at 10,000 g for 10 min. For immunopre-for 10 min. The cells were washed with Tris-buffered saline con-
taining 0.1% Triton X-100 (TBST) and blocked in TBST with 3% cipitation, the samples were then incubated with PSD-95 antibodies
(anti-rabbit, 1:100 dilution) for 1 hr at 4
C. After addition of 20 l ofnormal goat serum for 1 hr. Mouse monoclonal antibodies to PSD-
95 (#46; Affinity Bioreagents), NR1 (PharMingen), and synaptophysin protein A Sepharose beads (Pharmacia), samples were incubated
for 1 hr at 4
C. Immunoprecipitates were washed three times with(Sigma), and rabbit polyclonal antibodies to GluR1 (Upstate), NR2B
(Chemicon), synaptophysin (Sigma), and PSD-93 were used. Primary buffer containing TEE, 150 mM NaCl, and 1% Triton X-100, boiled
in SDS-PAGE sample buffer with 1 mM DTT for 2 min, and analyzedantibodies were added to blocking solution for 1 hr at RT followed
by donkey anti-mouse conjugated to Cy3 fluorophores (diluted 1:200 by SDS-PAGE. For fluorography, protein samples were separated
by SDS-PAGE and dried under vacuum. For 35S-labeled samples,in blocking solution) for 1 hr. Coverslips were then mounted on slides
(Frost Plus; Fisher) with Fluoromount-G (Southern Biotechnology gels were exposed to (Kodak Biomax MS) at 80
C for 3 to 5 days.
For 125I-labeled samples, gels were exposed to Kodak X-Omat MRAssociates), and images were taken under fluorescence microscopy
with a 60 objective affixed to a Zeiss inverted microscope. with intensifying screens at 80
C for 15 to 20 days.
Where indicated, protein synthesis blockers and glutamate recep-
tor agonists and antagonists were used at the following concentra- Subcellular Cell Fractionation
tions: cycloheximide (10 g/ml), APV (100 M), AMPA (100 M), Cultured cortical neurons (DIV 14–17; 12  106 cells) were treated
CNQX (100 M), and kynurenate (10 mM). For calcium depletion, for 8 hr in neurobasal media with or without 100 M palmitate or
4.75 mM EGTA was added to the neurobasal media, and MgCl2 was 2-Br palmitate. Cells were washed 1 with PBS, harvested, and
adjusted to a final concentration of 5 mM. then suspended in 200 l sonication buffer (50 mM Tris [pH 7.4],
0.1 mM EGTA) supplemented with a protease inhibitor cocktail (2.5
Quantitative Measurement of Protein Clustering g/ml leupeptin, 2.5 g/ml aprotinin, and 1 M PMSF). Cells were
and Receptor Internalization sonicated briefly and nuclei were pelleted at 14,000  g at 4
C for
Images of neurons were acquired with a CCD camera with a 60 10 min. Lysates were centrifuged at 49,000  g for 1 hr at 4
C. The
oil-immersion objective (NA 1.4) affixed to a Zeiss inverted micro- supernatants were collected and pellets were resuspended in 150
scope and quantitated using Metamorph imaging software (Univer- l resuspension buffer (RB; 50 mM Tris [pH 7.4], 0.1 mM EGTA, 1
sal Imaging). Protein clustering was quantified on 10 fields chosen M KCl, 10% glycerol, 1.5 l/10 ml BME and protease inhibitors).
randomly from at least 3 independent neuronal cultures as pre- Fractions (10 l each) were analyzed by SDS-PAGE and immu-
viously described (El-Husseini et al., 2000b). For each field, protein noblotting for PSD-95.
accumulation in synaptic puncta was determined by calculating the
average pixel intensity of puncta for PSD-95, PSD-93, NR2B, NR1, Electrophysiology
or GluR1, and comparing them to the average pixel intensity of
Whole-cell recordings were made from 21-to 22-day-old cultured
synaptophysin puncta present in the same field. Synaptic puncta
neurons, with 3–4 M patch pipettes. The pipette solution contained
were defined as sites containing synaptophysin and PSD-95, NR1,
(in mM): 115 Cs-MeSO3, 20 CsCl, 2.5 Mg2Cl, 10 HEPES, 0.6 EGTA,or GluR1 at intensities at least twice the dendritic background. Data
4 Na2ATP, 10 Na-phosphocreatinine, and 0.4 Na3GTP. Cultures werewere analyzed by t test using two-tailed distribution and two-sample
continuously superfused with buffer containing (in mM) 119 NaCl,
equal variance.
2.5 KCl, 10 glucose, 26 NaHCO3, 1 NaH2PO4, 2 CaCl2, 1.3 MgSO4,Internalization assays were done as described (Lin et al., 2000).
0.1 picrotoxin, and 0.001 TTX (saturated with 95%O2/5%CO2) at 1Briefly, live hippocampal neurons were labeled with an antibody (5
ml/min. Cells were patched under visual guidance using a water
g/ml) to an extracellular epitope of GluR1 (Oncogene Research).
immersion microscope. Current records were low-pass filtered at 2After washing with PBS, neurons were incubated with 100 M gluta-
kHz, stored on tape, and digitized off-line at 5 kHz.mate for 15 min. Cells were then washed and fixed with 4%
Cells were held at70 mV, and recording stability was monitoredparaformaldehyde 4% sucrose in PBS for 20 min. Cells were then
in real time using4 mV steps every 10 s. Series resistances rangedincubated with unlabeled anti-rabbit secondary antibodies for 1 hr
between 10 and 20 M, and did not differ between treatment groups.to block staining of surface receptors. Cells were then permeabilized
Recordings were made for up to 5 min from each cell, dependingwith 0.25% Triton for 5 min, followed by incubation with anti-rabbit
on mEPSC frequency (cells with higher frequencies were recordedCy3 to visualize internalized AMPA receptors. To avoid observer
for less time). mEPSCs were analyzed with customized softwarebias, slides were then coded and image analysis done without
(E. S.), using an amplitude threshold of 5 pA. Prior to recording,knowledge of the cDNA transfected. For image analysis, a cell was
cultures were treated for 8 hr with 20 M 2-Br palmitate (or vehiclecentered in the visual field and its body and dendrites within one
control) by a separate experimenter. An experimenter blinded withvisual field were analyzed. Automated analysis was performed using
regard to 2-palmitate treatment performed all recordings andcustom software routines in Northern Eclipse (EMPIX Imaging). For
mEPSC analyses. For dual component mEPSC recordings, the ex-each cell analyzed, AMPA receptor internalization was quantitated
ternal buffer contained 20 M glycine, and magnesium was omitted.as the fluorescence density of internalized AMPA receptor puncta.
This value was normalized to the average of nontransfected, non-
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